Gesundheit!
Some years ago, on England’s remote Isle of Man, an engineer named Mike James set out to devise a way to help his son who suffered from chronic sneezing attacks. After trial and error, Mike formulated a completely organic powdered plant extract, which created a gel when it came into contact with moisture. Observing that the gel was very similar to mucus, he had his son sniff the powder into his nose. His sneezing stopped immediately.
In the e-Alert “Next!” (7/31/02) I told you about Nasaleze, the product that was developed from Mike James’ formula. At that time, Nasaleze had plenty of enthusiastic users (including HSI Members), who had found great relief from both hay fever and eczema. But Nasaleze had not yet undergone any clinical trials.
One year later, not only do we have a hay fever trial to report on, but there’s also a new trial in the works to test Nasaleze on subjects with eczema. And if you’re wondering, “Hay Fever? Eczema? How to they relate?” The answer demonstrates just how unique this product is.
With flying colors
The hay fever study (appearing in the September 2003 issue of Alternatives in Natural Therapy) enlisted 102 adult volunteers (66 women and 36 men), who had suffered from hay fever for several years. Each subject completed a questionnaire at the outset of the study to rate their experiences with the most effective allergy drugs they had previously used.
Over a period of 42 days in the spring of 2003, all the volunteers kept daily diaries detailing the severity of allergy problems. Instructed to sniff one puff of Nasaleze into each nostril when allergies arose, the subjects then rated their response, with 1 being the most severe, and 5 being symptom free. Researchers also monitored pollen counts throughout the study, recording several periods when the counts were particularly high.
When the study was completed, researchers examined the data and found that overall, 77 percent of the subjects reported a significant reduction in allergy problems, and many said they had experienced their first symptom-free allergy season in years. Nasaleze’s final score on the 1-5 scale was 3.85, putting it very close to a rating of 4 which is described as “Quite well with occasional sneeze.”
This rating compared exceptionally well against the scores subjects gave in their initial questionnaires to brand name drugs. For instance, subjects had given an overall rating of 2.1 to Claritin, and 1.45 to Zyrtec. In addition, Nasaleze caused virtually no side effects, and was reported to be completely non-drowsy. And needless to say, since its natural ingredients don’t cause drowsiness, it doesn’t contain any synthetic agents to combat drowsiness.
Filtering the passage
So how does a simple vegetable powder – completely inert, with no pharmacologic action – manage to be more effective than high profile drugs that took millions of dollars to develop?
Last summer I traded e-mails with Mike James who explained that when people are allergic to pollen and other airborne pollutants, their bodies aren’t supplying enough mucus to properly filter air as it goes through the nasal passages. As a result, allergens make contact with the sinuses and lungs, triggering wheezing, sneezing, and other unpleasant reactions. Nasaleze naturally generates a substitute for the missing mucous, which protects sensitive areas.
Okay – good enough. But what about eczema? We’ve seen medicines that are effective for health problems they were never designed to address, but how could a medically inactive hay fever treatment relieve a skin condition?
Mike explained that when there’s a lack of “good quality mucus,” the resulting overload of pollution causes the natural purification system to break down and a number of defense systems are set into action. One of these systems is triggered by the mast cells (white blood cells) located in the upper nasal tract. The mast cells react to contact with allergens by firing histamine and other chemicals into the surrounding tissue. This creates typical allergy symptoms, and in some people is also known to cause eczema.
When Nasaleze restores the protective mucus, the nasal tract returns to its full working capacity as a filter. The defense system is no longer stimulated and the mast cells settle back down. Likewise, the chemical that causes eczema is inhibited and the eczema begins to recede. In most cases, hay fever symptoms are resolved in 10 seconds or less, asthma problems begin to clear up in a few hours, while eczema usually subsides within three weeks.
Where in the world is?
When I wrote to you about Nasaleze last summer, I told you that I was going to be brave and give it a try for my eczema. Unfortunately, my experiment wasn’t very successful. There are a number of different types of eczema, and Nasaleze addresses primarily atopic eczema, which is typically inherited. My eczema is triggered by stress.
But if you or someone you know has atopic eczema, there is an opportunity you may want to share with them. Enrollment is currently underway for the next Nasaleze trial. Already 150 subjects who suffer from atopic eczema have been recruited. Researchers are looking for another 50 subjects to round out the group. The test will require daily doses of either Nasaleze or a placebo for 6 weeks this coming autumn, 2003.
If you’re qualified for the study and would like to participate, send a self-addressed stamped envelope to:
The Herbal Health Centre
Department GIC/E, BATTLE
East Sussex TN33 9DP UK
Subjects need not live in the UK. All you need is a reliable postal service, wherever in the world you might be.
In addition to the eczema study, the other news coming from our UK contacts is that Nasaleze is now available in the U.S. under the name Sneeze-eze. If you haven’t tried Nasaleze and would like to, you can place an order online. For our members outside the U.S., visit nasaleze.com. If you live in the U.S., use this web site: sneezeeze.com. Both Nasaleze and Sneeze-eze offer money-back guarantees if you’re not completely satisfied, so both products are risk-free. And if you’re an HSI member, you should mention that when placing your order.
To Your Good Health,
Jenny Thompson
Health Sciences Institute
Sources:
“Abstract of Nasaleze Trial Results” Courtesy of Paul Duxbury, Kisska International Ltd.
“Nasaleze for the Treatment of Mild Eczema – a Double Blind Placebo Controlled Study” The Herbal Health Centre
“Mr. Sneeze in Drug Row” BBC News Online, 8/12/03, news.bbc.co.uk
